Company news
Aptorum Group Limited news in 2025
Aptorum Group Limited's news releases, calls and decks from 2025, newest first.
DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 Conference
November 19, 2025
Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering
October 10, 2025
As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives
October 9, 2025
Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 5, 2025
DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR’s APOE Genotyping Test
August 21, 2025
Aptorum Group Limited Regains Compliance with NASDAQ’s Minimum Bid Price Requirement
August 4, 2025
Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement
July 16, 2025
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
April 16, 2025
Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering
January 1, 2025